Taxonomy

CMT2F Study Achieves Recruitment Goal, Expands to Include Additional Participants

An international team of researchers from the Inherited Neuropathies Consortium

Read More

CMTA-STAR Advisory Board Member Dr. D’Antonio Publishes in Brain, Identifies Potential Therapeutic Target for CMT1B

CMTA is proud to share that research led by CMTA

Read More

Accelerating Genetic Therapy for CMT4B1: A CMTA Research Update

With CMTA’s support, researchers at San Raffaele Scientific Institute in

Read More

CMTA’s $300K Investment in CRISPR for CMT2A

The Charcot-Marie-Tooth Association (CMTA) is investing $300,000 in a groundbreaking

Read More

What’s New in CMT Research and Care? A 2025 Update Published by CMTA-STAR Advisory Board Member Davide Pareyson, MD

CMTA Strategy To Accelerate Research (CMTA-STAR) Advisory Board member and

Read More

CMTA Fuels Breakthrough Imaging Research to Address CMT2A’s Cellular Weakness

The Charcot-Marie-Tooth Association (CMTA) announces a $90,860 investment in a

Read More

Episode 3 of the Simply CMT Podcast with Dr. Katherine Forsey

Join us as we talk with Dr. Katherine Forsey, CMTA’s

Read More

Actio Biosciences Doses First Participant in Phase I Clinical Trial | Future Phase Ib Clinical Trial to Focus on CMT2C

CMTA-STAR Alliance Partner Actio Biosciences has announced that the first

Read More

CMTA-STAR Clinical Expert Board Co-Chair Prof. Mary Reilly Honored with Prestigious MBE

The Charcot-Marie-Tooth Association proudly celebrates Professor Mary M. Reilly, MD,

Read More

CMT-SORD: Bringing the Science Down to Earth | Shooting Star Ep. 3

Shooting Star brings science down to Earth, making complex CMT

Read More